• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Confidence intervals following group sequential tests.

作者信息

Chang M N, O'Brien P C

出版信息

Control Clin Trials. 1986 Mar;7(1):18-26. doi: 10.1016/0197-2456(86)90004-8.

DOI:10.1016/0197-2456(86)90004-8
PMID:3956209
Abstract

A procedure is proposed for obtaining confidence intervals for the probability of response following completion of a group sequential phase II trial. Numerical examples showed that, by ordering the sample space using the likelihood principle, we are able to shorten the length of the intervals and to obtain more accurate coverage of probability relative to previously proposed methods. The method may also be used for interval estimation following phase III trials.

摘要

相似文献

1
Confidence intervals following group sequential tests.
Control Clin Trials. 1986 Mar;7(1):18-26. doi: 10.1016/0197-2456(86)90004-8.
2
Confidence intervals for a normal mean following a group sequential test.
Biometrics. 1989 Mar;45(1):247-54.
3
Exact confidence intervals following a group sequential test.成组序贯检验后的精确置信区间。
Biometrics. 1984 Sep;40(3):797-803.
4
Estimation of a parameter and its exact confidence interval following sequential sample size reestimation trials.序贯样本量重新估计试验后参数估计及其精确置信区间
Biometrics. 2004 Dec;60(4):910-8. doi: 10.1111/j.0006-341X.2004.00246.x.
5
A design for phase II testing of anticancer agents within a phase III clinical trial.一种在III期临床试验中进行抗癌药物II期测试的设计。
Control Clin Trials. 1988 Jun;9(2):107-18. doi: 10.1016/0197-2456(88)90032-3.
6
On the estimation of the binomial probability in multistage clinical trials.关于多阶段临床试验中二元概率的估计
Stat Med. 2004 Mar 30;23(6):881-96. doi: 10.1002/sim.1653.
7
Confidence intervals following group sequential tests in clinical trials.临床试验中序贯检验后的置信区间。
Biometrics. 1987 Dec;43(4):857-64.
8
Interval estimates of the probability of toxicity at the maximum tolerated dose for small samples.小样本最大耐受剂量下毒性概率的区间估计。
Stat Med. 2003 Jun 15;22(11):1829-36. doi: 10.1002/sim.1443.
9
Conditional and unconditional confidence intervals following a group sequential test.成组序贯检验后的条件和无条件置信区间。
J Biopharm Stat. 2006;16(1):107-22. doi: 10.1080/10543400500406595.
10
Exact statistical inference for group sequential trials.序贯试验的精确统计推断。
Biometrics. 1991 Dec;47(4):1399-408.

引用本文的文献

1
Confidence Intervals for Adaptive Trial Designs I: A Methodological Review.适应性试验设计的置信区间I:方法学综述
Stat Med. 2025 Aug;44(18-19):e70174. doi: 10.1002/sim.70174.
2
Statistical inference for extended or shortened phase II studies based on Simon's two-stage designs.基于西蒙两阶段设计的扩展或缩短的II期研究的统计推断。
BMC Med Res Methodol. 2015 Jun 7;15:48. doi: 10.1186/s12874-015-0039-5.
3
Statistical issues for design and analysis of single-arm multi-stage phase II cancer clinical trials.单臂多阶段II期癌症临床试验设计与分析的统计学问题
Contemp Clin Trials. 2015 May;42:9-17. doi: 10.1016/j.cct.2015.02.007. Epub 2015 Mar 3.
4
A phase II trial and pharmacokinetic study of oxaliplatin in children with refractory solid tumors: a Children's Oncology Group study.奥沙利铂治疗耐药性实体瘤儿童的 II 期临床试验和药代动力学研究:一项儿童肿瘤学组研究。
Pediatr Blood Cancer. 2010 Sep;55(3):440-5. doi: 10.1002/pbc.22544.
5
Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies: a Children's Oncology Group study.静脉注射长春瑞滨(诺维本)用于复发性或难治性儿童恶性肿瘤的II期评估:一项儿童肿瘤学组研究。
Pediatr Blood Cancer. 2009 Oct;53(4):590-3. doi: 10.1002/pbc.22133.
6
Phase II study of intermediate-dose cytarabine in patients with relapsed or refractory Ewing sarcoma: a report from the Children's Oncology Group.复发或难治性尤因肉瘤患者中剂量阿糖胞苷的II期研究:来自儿童肿瘤学组的报告
Pediatr Blood Cancer. 2009 Mar;52(3):324-7. doi: 10.1002/pbc.21822.
7
A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: a report from the Children's Oncology Group.利妥昔单抗联合异环磷酰胺、卡铂和依托泊苷化疗用于复发/难治性B细胞(CD20+)非霍奇金淋巴瘤及成熟B细胞急性淋巴细胞白血病患儿的研究:儿童肿瘤协作组报告
Pediatr Blood Cancer. 2009 Feb;52(2):177-81. doi: 10.1002/pbc.21753.
8
A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group.丙卡巴肼与拓扑替康用于儿童高级别胶质瘤的II期窗口期试验:来自儿童肿瘤学组的报告
J Neurooncol. 2006 Apr;77(2):193-8. doi: 10.1007/s11060-005-9024-x.
9
A phase II study of thioTEPA in children with recurrent solid tumor malignancies: a Children's Cancer Group study.
Invest New Drugs. 1996;13(4):337-42. doi: 10.1007/BF00873141.